Permikson
Permikson: instructions for use and reviews
- 1. Release form and composition
- 2. Pharmacological properties
- 3. Indications for use
- 4. Contraindications
- 5. Method of application and dosage
- 6. Side effects
- 7. Overdose
- 8. Special instructions
- 9. Drug interactions
- 10. Analogs
- 11. Terms and conditions of storage
- 12. Terms of dispensing from pharmacies
- 13. Reviews
- 14. Price in pharmacies
Latin name: Permixon
ATX code: G04CX02
Active ingredient: creeping palm tree extract (serenoa repens fructuum extract)
Producer: Pierre Fabre Medicament Production (France)
Description and photo update: 2019-19-08
Prices in pharmacies: from 738 rubles.
Buy
Permikson is a herbal medicine with antiandrogenic, antiproliferative, anti-inflammatory and angioprotective action, which is used in the treatment of functional urinary disorders associated with prostate adenoma.
Release form and composition
Dosage forms of release:
- Film-coated tablets: green (in blisters of 15 pcs., 2 or 4 packages in a cardboard box);
- Capsules: light green, size 1; the capsules contain a pasty greenish substance, which has a characteristic odor (in blisters, 15 pcs., 2 packages in a cardboard box).
Composition of 1 coated tablet:
- Active ingredient: Serenoa repens fruits (lipidosterol extract) - 0.08 g;
- Auxiliary components: magnesium carbonate, magnesium stearate, glycerin, polyvidone, colloidal silica, wheat starch, kaolin, methylated casein, hydroxypropyl methylcellulose, titanium dioxide, quinoline yellow, indigo carmine.
Composition of 1 capsule:
- Active ingredient: Serenoa repens fruits (lipidosterol extract) - 0.16 g;
- Auxiliary components: gelatin, polyethylene glycol (macrogol 10,000), indigo carmine, titanium dioxide, yellow iron oxide.
Pharmacological properties
Pharmacodynamics
Permikson has a complex effect on the pathogenesis and symptoms characteristic of benign prostatic hyperplasia, which is explained by the complementary properties of the constituent components of this plant extract. Its antiandrogenic, antiproliferative, decongestant and anti-inflammatory effects are selectively manifested at the level of the prostate gland. At the same time, the drug does not change the concentration of sex hormones in the blood, does not affect the content of serum PSA (prostate-specific antigen) and does not lead to a deterioration in potency, libido and sexual functions. The local antiandrogenic effect of Permikson is due to the inhibition of the enzyme 5-alpha reductase types I and II, which is responsible for converting testosterone in the prostate gland into its pharmacologically active form - dihydrotestosterone,and a decrease in the binding of the latter to specific receptors. The consequence of a decrease in the synthesis of dihydrotestosterone is the inhibition of further growth of the prostate volume.
Local anti-inflammatory effect is associated with the effect of lipidosterol extract of creeping palm on the most important mediators of cellular inflammation (it weakens the activity of lipoxygenase, cyclooxygenase and phospholipase A 2). During the first weeks of therapy, the drug reduces vascular stasis, reduces capillary permeability, improves urodynamic parameters like alpha-blockers, eliminates edema and inflammation in the prostate, helps to get rid of compression of the urinary tract and bladder neck. The local antiproliferative effect of Permikson is expressed in a decrease in the activity of growth factors (primarily fibroblastic and epidermal) and an intensification of the processes of apoptosis of prostate cells, which is accompanied by a slowdown in growth and a subsequent decrease in the volume of the prostate gland. The above characteristics of Permikson provide a decrease in the severity of pathological symptoms, which is accompanied by benign prostatic hyperplasia (incomplete emptying of the bladder, dysuria, nocturia, pollakiuria,painful sensations and a feeling of tension during urination), as well as an increase in the volume and intensity of urination.
Pharmacokinetics
Information on the pharmacokinetics of the medicinal product is not provided by the manufacturer.
Indications for use
According to the instructions, Permikson is prescribed for the treatment of stages I and II of benign prostatic hyperplasia (adenoma).
Contraindications
Permikson is contraindicated for use in the presence of hypersensitivity to its components.
Instructions for the use of Permikson: method and dosage
The drug should be taken orally, preferably with meals.
The doctor determines the regimen individually.
Usually, the use of 0.32 g of the drug per day is shown (2 capsules or 4 tablets), the frequency of administration is 1 or 2 times a day.
The duration of the therapeutic course should be at least 3 months. Repeated courses are prescribed by a doctor if indicated.
Side effects
While taking Permikson, in some cases, disturbances in the form of nausea, gastralgia, heartburn are possible (usually, these side reactions go away on their own while taking the drug with food and do not require additional treatment).
Hypersensitivity reactions (allergic responses) may also occur.
Overdose
Overdose reports are almost never encountered. In case of accidental intake of the drug in high doses, it is recommended to perform gastric lavage.
special instructions
The development of disorders of the digestive system can be avoided by taking Permikson with meals.
Drug interactions
Antagonism of Permikson with drugs that are most often used during the treatment of adenoma (antibiotic, uroseptic and anti-inflammatory drugs) was not identified.
Analogs
Permikson's analogs are: Palprotes, Prostaplant, Prostamol Uno, Prostagut forte, Permikson
Terms and conditions of storage
Store at temperatures up to 25 ° C out of reach of children.
Shelf life:
- Film-coated tablets - 5 years;
- Capsules - 3 years.
Terms of dispensing from pharmacies
Available without a prescription.
Reviews about Permikson
On the Internet, there are often positive reviews about Permikson. Patients report an improvement in their well-being after the course of treatment: the majority of them decrease the frequency of urination, almost disappear pain in the perineum, and significantly improve the quality of life.
Price for Permikson in pharmacies
The approximate price for Permikson in the form of capsules is 725-980 rubles (for a package containing 30 pcs.). Film-coated tablets are currently not commercially available.
Permikson: prices in online pharmacies
|
Drug name Price Pharmacy |
|
Permikson 160 mg capsules 30 pcs. 738 RUB Buy |
|
Permikson capsules 160mg 30 pcs. 890 RUB Buy |
Anna Kozlova Medical journalist About the author
Education: Rostov State Medical University, specialty "General Medicine".
Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!
